Results 121 to 130 of about 2,111,387 (147)

Diuretics in Cardiovascular Disease: For How Long and at What Dose? [PDF]

open access: yesJ Cardiovasc Dev Dis
Paraskevaidis I, Tsougos E, Kourek C.
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Effects of an Oral Vasopressin Receptor Antagonist (OPC-31260) in a Dog With Syndrome of Inappropriate Secretion of Antidiuretic Hormone

Australian Veterinary Journal, 2000
ObjectiveThe syndrome of inappropriate secretion of antidiuretic hormone is a rare disorder in dogs characterised by hypo‐osmolality and persistent arginine vasopressin production in the absence of hypovolaemia and/or hypotension. The study describes the efficacy and safety of the nonpeptide selective arginine vasopressin V2receptor antagonist OPC ...
Peter Irwin, L M Fleeman, Pa Phillips
exaly   +6 more sources

Difference in Solute Excretion During Correction of Hyponatremic Patients With Cirrhosis or Syndrome of Inappropriate Secretion of Antidiuretic Hormone by Oral Vasopressin V2 Receptor Antagonist VPA-985

Translational Research, 2001
VPA-985 is an orally active, competitive vasopressin V(2) receptor antagonist that in normal human beings increases water excretion without affecting solute excretion. Whether solute excretion is affected in patients with hyponatremia resulting from inappropriate secretion of antidiuretic hormone (SIADH) or from cirrhosis treated with VPA-985 is ...
Guy Decaux
exaly   +4 more sources

Molecular Cloning of the Receptor for Human Antidiuretic Hormone

open access: yesNature, 1992
Antidiuresis, the recovery of water from the lumen of the renal collecting tubule, is regulated by the hypothalamic release of antidiuretic hormone (ADH), which binds to specific receptors on renal collecting tubule cells, stimulates adenylyl cyclase and
Philippe Brabet   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy